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The Feed Factor 
Estrogenic Variability in Lab
Animal Diets
Animal studies have long been a corner-
stone of biomedical and environmental
health research, and scientists need assur-
ance that animals used in these studies are
being cared for in ways that will not
unknowingly influence experimental out-
comes. But a growing number of scientists
have voiced concern over the possibility
that certain estrogenic compounds pre-
sent in lab animal feed may skew test
results. These compounds  are deemed
potentially problematic because they can
bind to estrogen receptors and induce
estrogen-like effects in animals, humans,
and cells grown in culture. Some experts
have advocated strict standardization of
rodent chows and even the removal of
dietary phytoestrogens.  
This emergent controversy was the
focus of “DIET II—The Effect of Vari-
ability in Estrogenic Activity of Com-
mercial Animal Feeds: Interaction with
Manufacturers, NIH Officials, and Scien-
tific Societies to Develop a Solution,” a
full-day meeting held 3 August 2006 in
Research Triangle Park, North Carolina.
The meeting, the second in a series on the
topic, was cosponsored by the NIEHS and
the NIH Office of Dietary Supplements
(ODS). Discussions at the meeting cen-
tered on the variation in estrogenic activity
between feed batches, the effects of these
estrogenic components on endocrine-
related end points, and the difficulties
inherent in comparing, interpreting, and
reproducing these end points over time
within and between different laboratories
when background levels of diet-related
estrogenic activity are not adequately doc-
umented. Findings presented at this meet-
ing made it clear that researchers studying
estrogen-related end points can not afford
to overlook the influence of the test
rodent’s diet.
“This workshop is an excellent exam-
ple of the cumulative and self-correcting
nature of the scientific process,” said
ODS nutritionist Elizabeth Yetley, a con-
ference co-organizer. “That is, through
the accumulation of results from a body
of experimental evidence, the importance
of approaches for better-defined animal
diets relative to their potential estrogenic
activity have been identified, and mea-
sures to improve future research in this
area are being undertaken by the scientific
community.”
Participants at the conference—orga-
nized by NIEHS scientists Jerrold
Heindel and Julius Thigpen, along with
Yetley and University of Missouri–
Columbia biologist Frederick vom Saal—
included investigators from the endocrine
disruptor research community as well as
representatives from animal feed compa-
nies. This spectrum of representatives
reflected the fact that, in Heindel’s words,
“researchers and animal care divisions of
research institutions are beginning to pay
attention to the phytoestrogen issue, and
feed manufacturers want to know what
the scientific community wants.” 
Heindel described a sincere interest on
the part of both sides to reach a “win–
win” solution, one that would yield ani-
mal diets of a known estrogenicity that
could be used by researchers in all fields
of physiology and toxicology, but that
also would not unduly burden the feed
manufacturers. 
The Chow Variable
The idea that a dietary background of
phytoestrogens may modulate some
responses to environmental estrogens in
rodent studies is not new. In the early
1980s, NIEHS investigators consulted the
institute’s Quality Assurance Laboratory
(QAL), headed by Thigpen, in an effort
to determine why scientists were unable
to duplicate data from outside laborato-
ries—or vice versa—and why sometimes
they couldn’t even duplicate their own
data. This led to the awareness that ani-
mals were being fed vastly different diets
not only in different labs but also within
the same lab. 
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It’s in there. Scientists and lab animal feed makers recently met to discuss problems resulting from
unwanted effects of phytoestrogenic components such as soy in animal diets.In the October 1987 issue of Labora-
tory Animal Science, Thigpen and col-
leagues reported for the first time that
commercially available rodent diets dif-
fered considerably in estrogenic activity.
Their conclusion: the composition of the
animal feed was important when perform-
ing or comparing results from studies
involving estrogenic compounds. At the
time, they proposed that a standardized
diet with minimal estrogenic activity
would be desirable for bioassays on estro-
genic substances.
Recent studies in the United States
and Europe have confirmed that the vari-
ability in estrogenic activity in rodent
diets is primarily due to the changing
phytoestrogen content—often the pro-
portion of soy isoflavones, although alfal-
fa and brewer’s yeast also contribute to
this effect. There appears to be tremen-
dous variation in isoflavone levels
between batches of the same feed. 
“We now know that the phytoestro-
gen content can vary three- to sixfold
between different batches of the same
diet, producing significant differences in
[developmental events] in mice,” says
Thigpen. “Researchers need to be con-
cerned about the background influence of
these dietary estrogens, particularly in
studies of estrogen-sensitive signaling
pathways and of the impact of endocrine-
disrupting chemicals on reproduction and
reproductive physiology.” 
To underscore the fundamental nature
of the debate, Thigpen emphasized at the
meeting that the diet selected for any con-
trolled study should reduce variables, not
increase them. For example, several stud-
ies—including one published in the May
2001 issue of Laboratory Investigation,
have shown that soy isoflavones provided
in standard rodent chow actually dimin-
ished the uterine effects of pharmaceutical
and industrial estrogens in ovariectomized
rats. There are also examples, says Hein-
del, where the positive estrogenic effect of
diethylstilbestrol was not detected in
experiments due to the high level of phy-
toestrogens in the diet. 
Working Around Phytoestrogens
Unfortunately, though manufacturers can
control how much soy protein goes into
feeds, they have no control over the
isoflavone content of the soybeans them-
selves. Variations in the isoflavone content
relate primarily to variations in climate,
timing of harvest, and storage. “Our scien-
tists have shown that there’s up to a
tenfold variation in the phytoestrogen
content of soybeans, and this is largely a
function of increased temperature,
increased water stress, and carbon dioxide
in the [soy] growing atmosphere,” says
David Klurfeld, a nutrition scientist with
the USDA Agricultural Research Service.
He notes that the recent heat wave on the
East Coast will likely impact the phyto-
estrogen content of soybeans, so that “next
year we’ll unknowingly be using soy-based
feeds and soy products that have a higher
phytoestrogen content.”
Kenneth Setchell, an isoflavone
researcher and pediatrics professor at the
University of Cincinnati College of
Medicine who coauthored the 2001
Laboratory Investigation paper, is dis-
turbed by what he perceives as a pervasive
lack of awareness concerning this issue.
“Very few researchers have a clue as to
what diet is being fed to their animals,”
Setchell said. Besides the fact that these
diets can have a profound impact on
physiology and thus on experimental out-
comes, when it comes to isoflavone con-
sumption rates and metabolic capacities,
many key differences exist between mice
and rats, between different strains of the
same species, and between rodents and
humans. “These differences could poten-
tially make it very difficult to compare
findings from different studies of the
same issue,” Setchell said.
Compared to humans, for example,
rodents consume far more isoflavones per
unit of body weight and produce much
more S-equol (relative to R-equol, which
is higher in humans), a phytoestrogen
metabolite that closely resembles estradi-
ol. It also has been demonstrated that
Sprague-Dawley rats are much less sensi-
tive than other lab rat species to the
effects of phytoestrogens.
One suggestion at the meeting was that
estrogenic activity of feeds be reported in
every scientific paper that has an endocrine
component. But Setchell pointed out the
potential for phytoestrogens affecting
nonendocrine end points as well. He
recounted the story of a biology professor
who was studying a rodent gene knock-out
model for cardiomyopathy. This particular
model typically succumbs to congestive
heart failure in the first days of life. “[The
investigator] noticed that animals fed a
standard Purina animal chow were not
dying on schedule,” said Setchell.
“Evidently something in the Purina chow
was curbing the development of cardiomy-
opathy.” That something turned out to be
phytoestrogens, and specifically the
isoflavones from soy protein. 
A similar argument for reporting estro-
genic activity of animal feeds can be made
in the context of studying neurobehavioral
disorders, as dietary phytoestrogens may
influence these outcomes as well, with
both high and low levels associated with
adverse effects in animal models. A study
in the January–February 2002 issue of
Neurotoxicology and Teratology showed that
the soy phytoestrogen content of the diet
exerts specific influences on learning,
memory, and anxiety-related behaviors. In
one set of experiments, for example,
researchers found that adult rats fed a
“phyto-rich diet” had more anxiolytic
effects than animals fed a “phyto-free diet.”
Data presented by vom Saal indicated
that even diets thought to be devoid of
phytoestrogens—such as diets based on
casein, a milk protein—may contain sig-
nificant amounts of estrogenic activity
and that that estrogenic activity can vary
up to sixfold from batch to batch. Thus,
even switching to a casein-based diet
would not prevent the problem of vari-
able estrogenicity of animal diets. 
The key, vom Saal argued, is to try to
find a feed that provides the optimal level
of serum estradiol during and after preg-
nancy—this could mean different diets for
these different life stages. “We believe that
there are animal diets that allow us to
study rodents in ways that are highly pre-
dictive of human health outcomes,” he
said; for example, one such diet consists of
a typical soy-containing feed that is rough-
ly comparable to what a mouse foraging in
a natural environment might consume.
“On the other hand,” he said, “some
[rodent] diets can change the animal so
profoundly that it’s unusable for those
experiments.”
Retha Newbold, a developmental
reproductive biologist at the NIEHS
Laboratory of Molecular Toxicology, has
investigated the effects of phytoestrogens
and endocrine-disrupting chemicals for
years. She noted, “There are some experi-
mental animals that simply thrive and
reproduce better on diets with phyto-
estrogens.” Further, she added, it should
be up to the investigators themselves to
determine if their particular experiment
calls for a phytoestrogen-free diet or not,
but certainly researchers need to know the
phytoestrogen content and the hormonal
activity of the feed they are using.
Recommendations and Agreements
At this time, it may be impossible to deter-
mine to what extent phytoestrogens in
animal diets have affected the results of
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the workshop would disagree that the con-
cern is real, given what is now known
about these compounds’ substantial vari-
ability, potency, and ability to significantly
alter molecular end points and gene
expression.
Scientists at the meeting agreed that
the background estrogenic activity effects
of animal feeds are important and need to
be controlled. They also agreed that there
can not be one optimal diet for all
research. Deciding on a standard rodent
diet will likely depend on the specific
objectives of the study and on the end
points being evaluated. There was also
consensus that many animal researchers are
not aware of the problems posed by not
knowing the hormonal activity of their
diets and how this activity can vary from
batch to batch. 
Participants further agreed that simply
stating there are no known sources of
estrogenicity in diets is not sufficient; total
estrogenicity of diets needs to be measured.
They also agreed to work with feed manu-
facturers so that researchers could have
access to diets with known estrogenicity.
This would not mean that manufacturers
would need to produce new diets, but only
that they test diets for total estrogenicity
including the presence of phytoestrogens,
mycotoxins, zearalenone, and any other
ingredient that might cause an estrogenic
or hormonal response in animals. 
The actual details of the testing and
reporting of the results were not complete-
ly worked out, but participants concluded
that the best solution would be to perform
assays for known hormonally active chemi-
cals and bioassays that could identify hor-
monal activity of unknown sources. Future
research will be needed to determine the
range of estrogenic activity for a particular
type of feed that would be acceptable and
that would not significantly alter the lab
animal’s phenotype or interfere with
responses to exogenously administered
estrogens in bioassays.
“The NIEHS workshop sought to
address a very complex and challenging
methodological issue involved in the study
of one type of bioactive substances found
in foods and dietary ingredients,” said
Yetley. “As such, the findings from this
workshop will not only help to improve
the quality of future research related to
phytoestrogens, but will also help inform
us of better ways to deal more generally
with similar methodological challenges
with other botanical and food-derived sub-
stances.” –M. Nathaniel Mead
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Headliners Genetic Research
NIEHS-Supported Research
Polymorphisms Modify Breast Cancer Risk in Smokers
Mechanic LE, Millikan RC, Player J, de Cotret AR, Winkel S, Worley K, et al. 2006.
Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in
African Americans and whites: a population-based case–control study. Carcinogenesis
27:1377–1385.
Previous research has established cigarette smoking as a risk factor for a
number of cancers, including those of the lung, pancreas, and head and
neck. A link between cigarette smoking and breast cancer is not as clear;
however, scientists do know that breast cancer occurs at different rates in
different racial groups. In this paper, NIEHS grantee Robert C. Millikan of the
University of North Carolina at Chapel Hill and his colleagues document find-
ings suggesting that specific combinations of polymorphisms on certain
nucleotide excision repair (NER) genes may modify the risk of breast cancer
in black women who smoke.
NER is the primary means by which smoking-induced DNA damage is
repaired. There are several known polymorphisms on genes involved in NER.
These investigators conducted a genetic epidemiologic study aimed at deter-
mining whether such polymorphisms alter the association between smoking
and breast cancer. 
The investigators analyzed exposure histories and DNA samples extracted
from peripheral blood lymphocytes of 3,863 women (1,449 black, 2,414
white) aged 21 to 74. The women were participating in the Carolina Breast
Cancer Study, a large population-based case–control study of breast cancer
in North Carolina. Next the investigators calculated odds ratios for breast
cancer and smoking and for breast cancer and nine polymorphisms on six
NER genes. Then they examined how odds ratios for smoking were modified
by single and combined NER genotypes. 
In general, they found, smoking was more strongly associated with
breast cancer in black women than in white women. The association
increased even more for black women with particular patterns of polymor-
phisms when combined with different smoking characteristics including
amount of smoking, duration, time since smoking cessation, age at smoking
initiation, and being a former smoker. No interactions were seen in white
women.
The investigators believe this is the first study to examine multiple NER
polymorphisms together as susceptibility factors for breast cancer in combi-
nation with smoking. Further studies with larger numbers of participants are
needed to confirm these results. –Jerry Phelps